Free Call: 1800 792 676
Seminar Invitation: Pitfalls for SMEs in protecting and claiming incentives for new developments
Presented by:
- Joe Seisdedos (Wrays)
- Glenn Cosgrave (Bates Cosgrave)
- Adam Rogers (Swanson Reed)
Join Swanson Reed, Bates Cosgrave and Wrays for a practical workshop that will focus on the problems that every day companies face in protecting, and claiming incentives for their new products.
You will hear from three industry experts on a range of topics, including tax issues, R&D tax incentives and patent protection.
On conclusion of the presentation, participants will have an opportunity to ask the panel any specific questions in a friendly and constructive forum.
| Time | Presentation | Presenter | |
| 7:00am – 7:30am: | Session 1: Protecting Intellectual Property (IP) | Joe Seisdedos | |
| 7:30am – 8:00am: | Session 2: IP & Relevant Tax Considerations | Glenn Cosgrave | |
| 8:00am – 8:30am: | Session 3: R&D Tax Incentives | Adam Rogers | |
| 8:30am – 9:00am: | Session 4: Panel Q&A and Networking Opportunity | ||
| Joe Seisdedos | Glenn Cosgrave | Adam Rogers |
 |
 |
 |
Sydney Seminar:
Tuesday, 17th June 2014
7am – 9am
Hilton Sydney
488 George Street
Sydney, 2000
Cost: Free!
Register Before: Friday 13th June
Full attendance at this workshop will yield 2 CPE hours towards the Tax Practitioners Board’s (TPB) CPE requirements.
Contact Amy Nolan for more information:
Ph: 02 8006 9155
Mob: 0435 713 493
Are you Eligible to claim R&D? Take our R&D Eligibility Survey and find out.
Latest News
Draft AusIndustry Determination on Clinical Trials (Phase 0-III) for an Unapproved Therapeutic Good
AusIndustry has recently released a draft Industry Research and Development (clinical trials, Phase 0, I, II, III for an unapproved therapeutic good) Determination 2021 for consultation and feedback. This is the first R&D Tax Incentive determination published, and AusIndustry noted that they have consulted with the Australian Taxation Office and Department of Health as part of the coalition of this document. The draft document notes that: In respect of classifying the phase of a trial: Phase 0 clinical trial means […]
ATO Release Finalised Tax Ruling TR 2021/9 (Adjustments to R&D Claims for Job Keeper)
In July 2020, The ATO released TD 2020/D1: Income tax: notional deductions for research and development activities subsidised by JobKeeper payments. The ruling outlined the need for companies that are subject to both the R&D Tax Incentive and JobKeeper to adjust R&D claims on the basis that: The “at-risk” rule applies to R&D salaries reimbursed by Jobkeeper, and a company cannot notionally deduct the portion of wage expenditure incurred on R&D activities that has been subject to the JobKeeper payment; […]
Quick Contact
News & Research
News & Research
News & ResearchDraft AusIndustry Determination on Clinical Trials (Phase 0-III) for an Unapproved Therapeutic Good
AusIndustry has recently released a draft Industry Research and Development (clinical trials, Phase 0, I, II, III for an unapproved therapeutic good) Determination 2021 for consultation and feedback. This is the first R&D Tax Incentive determination published, and AusIndustry noted […]
ATO Release Finalised Tax Ruling TR 2021/9 (Adjustments to R&D Claims for Job Keeper)
In July 2020, The ATO released TD 2020/D1: Income tax: notional deductions for research and development activities subsidised by JobKeeper payments. The ruling outlined the need for companies that are subject to both the R&D Tax Incentive and JobKeeper to […]
